Prevention of
influenza episodes with Colostrum compared with vaccination in
healthy and high-risk cardiovascular
subjects:
The epidemiologic study in
San Valentino.
Cesarone MR, Belcaro G, Di Renzo
A, Dugall M, Cacchio M, Ruffini I, Pellegrini L, Del Boccio G,
Fano F, Ledda A, Bottari A, Ricci A, Stuard S, Vinciguerra
G.
San Valentino-Spoltore Vascular Screening Project,
Department of Biomedical Sciences, G D'annunzio University,
Chieti, Pescara, Italy.
The efficacy of a 2-month treatment
with oral colostrum in the prevention of flu episodes compared
with antiinfluenza vaccination was evaluated. Groups included
healthy subjects without prophylaxis and those receiving both
vaccination and colostrum. After 3 months of follow-up, the
number of days with flu was 3 times higher in the non-colostrum
subjects. The colostrum group had 13 episodes versus 14 in the
colostrum + vaccination group, 41 in the group without
prophylaxis, and 57 in nontreated subjects. Part 2 of the study
had a similar protocol with 65 very high-risk cardiovascular
subjects, all of whom had prophylaxis.
The incidence of
complications and hospital admission was higher in the group
that received only a vaccination compared with the colostrum
groups. Colostrum, both in healthy subjects and high-risk
cardiovascular patients, is at least 3 times more effective
than vaccination to prevent flu and is very
cost-effective.
PMID: 17456621 [PubMed - indexed
for MEDLINE]
|